At baseline, temporal and parietal brain areas had significantly higher tracer retention in AD patients relative to controls. Tracer retention was positive correlated with a worsening of dementia and cognitive status, in addition to brain atrophy. Annual increases of 13.2% were observed for AD patients in terms of TSPO tracer binding. This evidence concerns the gene TSPO and dementia.